Regeneron Pharmaceuticals Inc. buy Royal Bank of Canada
Summary
This prediction is currently active. With a performance of 1.66%, the BUY prediction by Royal_Bank_of_Canada for Regeneron Pharmaceuticals Inc. is trending in the right direction. This prediction currently runs until 24.09.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
Name | 1w |
---|---|
Regeneron Pharmaceuticals Inc. | 1.66% |
iShares Core DAX® | 1.518% |
iShares Nasdaq 100 | 1.240% |
iShares Nikkei 225® | 2.808% |
iShares S&P 500 | 0.403% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Stopped prediction by Royal_Bank_of_Canada for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
17.09.24
17.09.25
26.09.24
Regeneron Pharmaceuticals Inc.
05.09.24
05.09.25
26.09.24
Regeneron Pharmaceuticals Inc.
02.08.24
02.08.25
26.09.24
Regeneron Pharmaceuticals Inc.
24.06.24
24.06.25
26.09.24
Regeneron Pharmaceuticals Inc.
12.06.24
12.06.25
26.09.24
Regeneron Pharmaceuticals Inc.
04.06.24
04.06.25
26.09.24
Regeneron Pharmaceuticals Inc.
09.04.24
09.04.25
26.09.24
Regeneron Pharmaceuticals Inc.
27.02.24
27.02.25
26.09.24
Regeneron Pharmaceuticals Inc.
05.02.24
05.02.25
26.09.24
Regeneron Pharmaceuticals Inc.
29.01.24
29.01.25
26.09.24
Regeneron Pharmaceuticals Inc.
12.01.24
12.01.25
26.09.24